Insider · CIK 0001303521

Fuhrman Alan

Reports to the SEC for 8 companies · CARLSBAD, CA

sec.gov

Transactions

Companies

Filings

CIK

0001303521

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-15	TYRATyra Biosciences, Inc.A Award	Chief Financial Officer	AAward	+951 sh	$9.13	+$8,681.679	37,115
2026-05-05	TYRATyra Biosciences, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+67K sh	—	—	67,000
2026-05-05	TYRATyra Biosciences, Inc.A Award	Chief Financial Officer	AAward	+20K sh	—	—	36,164
2026-03-13	TYRATyra Biosciences, Inc.A Award	Chief Financial Officer	AAward	+1,376 sh	$9.13	+$12.6K	16,164
2025-09-15	TYRATyra Biosciences, Inc.A Award	Chief Financial Officer	AAward	+701 sh	$9.13	+$6,399.429	14,788
2025-08-07	TYRATyra Biosciences, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+170K sh	—	—	170,000
2025-07-01	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−30K sh	—	—	0
2025-07-01	SpringWorks Therapeutics, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−24.7K sh	—	—	0
2025-07-01	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−13.8K sh	—	—	0
2025-07-01	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12.2K sh	—	—	0
2025-07-01	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−15.3K sh	—	—	0
2025-07-01	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−7,464 sh	—	—	0
2025-05-14	SpringWorks Therapeutics, Inc.A Award	Director	AAward	+10.1K sh	—	—	24,727
2025-03-14	TYRATyra Biosciences, Inc.A Award	Chief Financial Officer	AAward	+1,238 sh	$9.78	+$12.1K	14,087
2024-10-30	TYRATyra Biosciences, Inc.P Purchase	Chief Financial Officer	PPurchase	+9,500 sh	$16.00	+$152K	12,849
2024-09-13	TYRATyra Biosciences, Inc.A Award	Chief Financial Officer	AAward	+954 sh	$12.48	+$11.9K	3,349
2024-08-14	TYRATyra Biosciences, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+115K sh	—	—	115,000
2024-05-23	ESPREsperion Therapeutics, Inc.A Award	Director	AAward	+23K sh	—	—	53,404
2024-05-23	ESPREsperion Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+32.5K sh	—	—	32,500
2024-05-16	SpringWorks Therapeutics, Inc.A Award	Director	AAward	+4,095 sh	—	—	14,667
2024-05-16	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+12.2K sh	—	—	12,216
2024-03-15	TYRATyra Biosciences, Inc.A Award	Chief Financial Officer	AAward	+932 sh	$12.48	+$11.6K	2,395
2023-09-15	TYRATyra Biosciences, Inc.A Award	Chief Financial Officer	AAward	+1,463 sh	$12.50	+$18.3K	1,463
2023-07-28	TYRATyra Biosciences, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+62.7K sh	—	—	62,685
2023-06-15	ESPREsperion Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+21K sh	—	—	21,000
2023-06-15	ESPREsperion Therapeutics, Inc.A Award	Director	AAward	+5,150 sh	—	—	30,404
2023-05-24	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+13.8K sh	—	—	13,774
2023-05-24	SpringWorks Therapeutics, Inc.A Award	Director	AAward	+4,648 sh	—	—	10,572
2023-01-01	TYRATyra Biosciences, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+32.8K sh	—	—	32,800
2023-01-01	TYRATyra Biosciences, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+328K sh	—	—	328,000
2022-05-31	Checkmate Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−22.7K sh	—	—	0
2022-05-31	Checkmate Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−247K sh	—	—	0
2022-05-31	Checkmate Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2022-05-26	ESPREsperion Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2022-05-19	SpringWorks Therapeutics, Inc.A Award	Director	AAward	+4,818 sh	—	—	5,924
2022-05-19	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+15.3K sh	—	—	15,318
2021-10-27	Checkmate Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+247K sh	—	—	246,671
2021-06-16	Checkmate Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,030
2021-05-27	ESPREsperion Therapeutics, Inc.A Award	Director	AAward	+12.4K sh	—	—	25,254
2021-05-20	SpringWorks Therapeutics, Inc.A Award	Director	AAward	+1,106 sh	—	—	25,227
2021-05-20	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+6,998 sh	—	—	6,998
2020-05-28	ESPREsperion Therapeutics, Inc.A Award	Director	AAward	+1,221 sh	—	—	12,878
2020-05-20	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+7,464 sh	—	—	7,464
2020-05-15	ESPREsperion Therapeutics, Inc.A Award	Director	AAward	+11K sh	—	—	11,657
2019-09-12	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+30K sh	—	—	29,983
2019-02-15	Loxo Oncology, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−13K sh	$235.00	−$3.06M	0
2019-02-15	Loxo Oncology, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−8,750 sh	$235.00	−$2.06M	0
2019-02-15	Loxo Oncology, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−11K sh	$235.00	−$2.59M	0
2019-02-15	Loxo Oncology, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−7,812 sh	$235.00	−$1.84M	0
2019-02-15	Loxo Oncology, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−7,812 sh	$235.00	−$1.84M	0

Recent filings

Accepted (ET)
Sep 174
Fuhrman Alan0001193125-26-394731
SEC(opens sec.gov)
May 74
Fuhrman Alan0001193125-26-212115
SEC(opens sec.gov)
Mar 174
Fuhrman Alan0001193125-26-111100
SEC(opens sec.gov)
Sep 174
Fuhrman Alan0001193125-25-206439
SEC(opens sec.gov)
Aug 74
Fuhrman Alan0000950170-25-105153
SEC(opens sec.gov)
Jul 24
Fuhrman Alan0001104659-25-065312
SEC(opens sec.gov)
May 154
Fuhrman Alan0001104659-25-049658
SEC(opens sec.gov)
Mar 184
Fuhrman Alan0000950170-25-041550
SEC(opens sec.gov)
Nov 14
Fuhrman Alan0000950170-24-120099
SEC(opens sec.gov)
Sep 174
Fuhrman Alan0000950170-24-107391
SEC(opens sec.gov)
Aug 164
Fuhrman Alan0000950170-24-098150
SEC(opens sec.gov)
May 244
Fuhrman Alan0001628280-24-025219
SEC(opens sec.gov)
May 174
Fuhrman Alan0001104659-24-062978
SEC(opens sec.gov)

Companies

Address

C/O TYRA BIOSCIENCES, INC. 2656 STATE STREET

CARLSBAD, CA, 92008